CD Formulation Unveils Hygroscopicity Evaluation for Drug Formulation

Open Health Network Launches PatientSphere 2.0 for Cardiology

Open Health Network (OHN) announces the launch of PatientSphere 2.0 for Cardiology, an online system that connects a team of diverse providers to tightly coordinate care for patients with chronic heart conditions. The system offers an evidence-based approach to the real-time integration of every aspect of chronic cardiology care, delivering improved patient outcomes and reducing complexity costs. PatientSphere 2.0 for Cardiology incorporates all the capabilities of its predecessors, PatientSphere and Constant Care. The system also can be modified to support research, clinical and prevention applications in many other indications, both common and rare diseases, including cancer, gastrointestinal disease, diabetes, asthma and sickle cell disease.

STEMart Launches Medical Device Irritation Testing Service

STEMart launches medical device irritation testing service following the biocompatibility guidelines modified for medical devices.

Amerigo Scientific Launches PNGase F for Glycan Release

Amerigo Scientific introduces PNGase F for life science researchers.

Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes

Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes

Torx Software completes release of Torx™, a single web-based platform that will streamline small molecule discovery chemistry

Torx Software Limited announces the release of Torx Test™ and Torx Analyze™ to complete the Torx platform for small molecule discovery chemistry.

Global PharmaceuticalCompany proves validity of AI in life sciences through Pangaea Data’s novel Natural Language Generation driven product

Leading global pharmaceutical company presented Pangaea Data’s Novel AI to Automatically Generate Textual Clinical Narratives for Regulatory Reports

Firstsource and Eco-Mail Partner to Strengthen Workflow Digitization for Health Plans Amidst Permanent Shift to a Remote Workforce

VisualDx Announces Additions to Executive Team to Meet Demand to Improve Health Outcomes

Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category

The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

eClinicalWorks Creates a Centralized Platform and Drives Patient Engagement for 50+ Providers at Soma Medical Center, P.A.

Rho’s Chief Medical Officer Jack Modell Presenting During 12th Annual CNS Summit

Rho, a full-service contract research organization (CRO), is showcasing its clinical development expertise during the 12th Annual CNS Summit, taking place at the Encore Boston Harbor Hotel from November 7-10, 2021. Rho’s Chief Medical Officer, Dr. Jack Modell, along with Dr. John Greist and Dr. Thomas Laughren, will present during a Spotlight Session at the Summit. The 50-minute breakout session, titled, “The Seven Essentials of Clinical Development: How to Avoid Shooting Yourself in the Foot” will showcase the speakers’ combined experience in clinical medicine, academic research, regulatory affairs, and development of drugs and medical applications of information technology.

Creative Biostructure Enlarged Its Protein Crystallization Kits Offerings

CD ComputaBio Announces 3D-QSAR Service for Drug Design and Screening

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company has recently launched 3D-QSAR services for scientists to accelerate the drug development process.

Antibiotic Research UK’s annual lecture calls for global governments to transform funding of new antibiotic sales to prevent another health emergency

The UK’s first charity focused on antibiotic resistance, Antibiotic Research UK (ANTRUK), hosted its annual lecture in London on Thursday 21st October to bring together experts in research, health economics and politics.

Praxis Bioresearch Seeks Regulatory Strategy Support from MMS Holdings to Develop Therapeutics for Alzheimer’s Disease

MMS Holdings – a data-focused clinical research organization – supported Praxis Bioresearch in the development of a therapeutic for apathy in Alzheimer’s disease. Praxis recently received a $2.9 Million Fast-Track SBIR Grant, which, along with the positive clinical data from the Phase 0 program, means the company’s lead development candidate can now advance to early clinical development.

CluePoints Shortlisted for Multiple Awards in Recognition of Pioneering Risk-Based Quality Management Solution

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for three international awards. CluePoints, BioNTech and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty) has been selected as a finalist for the Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award at the Scrip Awards. The company is also in the running for two Citeline Awards: ´Best Sponsor-facing Technology Initiative´ for their business intelligence platform, BEYOND. As well as ´Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities´, for its work with Pfizer / BioNTech.

AVIA Expands Leadership Team to Support Industry Demand for Digital Advancement, Commitment to Operational Excellence

AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced today the expansion of its leadership team to support the substantial growth of the company in 2021

Purdue University and physIQ partner to develop a smartwatch-based algorithm to detect early signs of viral infections, including COVID-19

Purdue University and physIQ, a leader in digital medicine, announced Thursday (Oct. 28) the co-development of a viral detection algorithm for smartwatches. This innovation will be the result of a collaboration between physIQ and university engineers. The algorithm will be commercialized by physIQ, which develops solutions designed to improve health care outcomes by applying artificial intelligence to real-time physiological data from wearable sensors.